Trial
NCT03193333
PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle Glaucoma (PRO-122LATAM)
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Laboratorios Sophia S.A de C.V.
Collaborators
—
Condition
Primary Open-angle Glaucoma
Intervention
PRO-122
Why stopped
Sponsor's prerogative since initial purpose for study shifted according to business strategy.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-06